BioCentury
ARTICLE | Financial News

Xanthus raises $30.8 million

December 12, 2003 8:00 AM UTC

Cancer company Xanthus (Cambridge, Mass.) raised $30.8 million in a series B round led by Oxford Bioscience. Other investors included CDP Capital - Technology Ventures; Hambrecht & Quist; GIMV; Genechem; China Development Industrial Bank; CDIB BioScience Ventures; Yasuda.; HealthCare Ventures; Still River Fund; and Kestrel Management. ...